Carol Tamminga

Carol A. Tamminga is an American psychiatrist and neuroscientist, focusing in treating psychotic illnesses, such as schizophrenia, psychotic bipolar disorder, and schizoaffective disorder, currently the Lou and Ellen McGinley Distinguished Chair in Psychiatric Research at University of Texas Southwestern Medical Center and is an Elected Fellow of the National Academy of Medicine. She serves on the advisory boards of the Brain and Behavioral Research Foundation and of the National Institute of Mental Health (NIMH).[1] In 2011 she was awarded the Lieber Prize for Outstanding Achievement in Schizophrenia Research.[2] Tamminga led a study examining whether giving Prozac to fetuses with Down syndrome would improve the functioning of their brains.[3][4] In her attempt to confirm psychiatric diagnoses biologically, she found "biotypes" or "clusters."[5] Her current research involves mechanisms underlying schizophrenia, especially its most prominent symptoms, psychosis and memory dysfunction.[6][7][8]

References
  1. "Carol Tamminga, M.D.: Psychiatry | UT Southwestern Medical Center". utswmed.org. Retrieved 2019-03-24.
  2. "Past Outstanding Achievement Prizewinners". Brain & Behavior Research Foundation. 2017-04-11. Retrieved 2019-03-07.
  3. "Could An Antidepressant Help Kids With Down Syndrome?". Popular Science. Retrieved 2019-03-09.
  4. Bryan, Ellen. "Study Gives Prozac to Fetuses With Down Syndrome". NBC 5 Dallas-Fort Worth. Retrieved 2019-03-09.
  5. Carreon, David; Gold, Jessica (Aug 28, 2018). "The Last Undiscovered Organ in the Body". Psychiatric Times.
  6. "Carol Tamminga". utsouthwestern.edu. Retrieved May 12, 2017.
  7. "Questions". utsouthwestern.edu. Retrieved May 12, 2017.
  8. "Lab". utsouthwestern.edu. Retrieved May 12, 2017.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.